BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37657065)

  • 1. Molecular mechanism of Ruxian Shuhou prescription in the treatment of triple-negative breast cancer based on network pharmacology.
    Chu M; Meng T; Zhou Y; Jin L; Dai Q; Ma L; Chen H
    Medicine (Baltimore); 2023 Sep; 102(35):e34763. PubMed ID: 37657065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the mechanism of Prunella vulgaris in treatment of papillary thyroid carcinoma based on network pharmacology integrated molecular docking and experimental verification.
    Zhu X; Li Y; Wang X; Huang Y; Mao J
    Medicine (Baltimore); 2023 Apr; 102(17):e33360. PubMed ID: 37115092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking.
    Yao T; Wang Q; Han S; Lu Y; Xu Y; Wang Y
    Biomed Res Int; 2022; 2022():9214589. PubMed ID: 35837376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network pharmacology and molecular docking-based analyses to predict the potential mechanism of Huangqin decoction in treating colorectal cancer.
    Li YJ; Tang DX; Yan HT; Yang B; Yang Z; Long FX
    World J Clin Cases; 2023 Jul; 11(19):4553-4566. PubMed ID: 37469733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the mechanism of Xiaoqinglong decoction in the treatment of infantile asthma based on network pharmacology and molecular docking.
    Chen D; Chen Q; Zhao K; Guo Y; Huang Y; Yuan Z; Cai Y; Li S; Xu J; Lin X
    Medicine (Baltimore); 2023 Jan; 102(2):e32623. PubMed ID: 36637916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unveiling the Mechanism of the ChaiShao Shugan Formula Against Triple-Negative Breast Cancer.
    Fan T; Huang Y; Liu Z; Huang J; Ke B; Rong Y; Qiu H; Zhang B
    Drug Des Devel Ther; 2024; 18():1115-1131. PubMed ID: 38618280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanism of oroxyli semen against triple-negative breast cancer verified by bioinformatics and in vitro experiments.
    Chen L; Yang A; Li Y; Liu X; Jiang W; Hu K
    Medicine (Baltimore); 2023 Sep; 102(37):e34835. PubMed ID: 37713894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network pharmacology prediction and molecular docking-based strategy to discover the potential pharmacological mechanism of Huang-Qi-Gui-Zhi-Wu-Wu decoction against deep vein thrombosis.
    Fan W; Lan S; Yang Y; Liang J
    J Orthop Surg Res; 2023 Jun; 18(1):475. PubMed ID: 37391801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analyzing network pharmacology and molecular docking to clarify Duhuo Jisheng decoction potential mechanism of osteoarthritis mitigation.
    Cui Z; Zhang W; Le X; Song K; Zhang C; Zhao W; Sha L
    Medicine (Baltimore); 2022 Dec; 101(50):e32132. PubMed ID: 36550856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virtual screening of the multi-gene regulatory molecular mechanism of Si-Wu-tang against non-triple-negative breast cancer based on network pharmacology combined with experimental validation.
    Zhang Z; Liu J; Liu Y; Shi D; He Y; Zhao P
    J Ethnopharmacol; 2021 Apr; 269():113696. PubMed ID: 33358854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network Pharmacology and Experimental Validation to Explore the Effect and Mechanism of Kanglaite Injection Against Triple-Negative Breast Cancer.
    Zhao M; Fu L; Xu P; Wang T; Li P
    Drug Des Devel Ther; 2023; 17():901-917. PubMed ID: 36998242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the mechanisms of Gui Zhi Fu Ling Wan on varicocele via network pharmacology and molecular docking.
    Wang R; Qiao X; Wang X
    Andrologia; 2022 Dec; 54(11):e14635. PubMed ID: 36372090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network pharmacology-based prediction and validation of the active ingredients and potential mechanisms of the Huangxiong formula for treating ischemic stroke.
    Zhao S; Zhang P; Yan Y; Xu W; Li J; Wang L; Wang N; Huang Y
    J Ethnopharmacol; 2023 Aug; 312():116507. PubMed ID: 37080367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of Key Ingredient of Astragalus membranaceus on Lung Adenocarcinoma via PI3K/AKT Signaling Clarified by Utilizing Network Pharmacology Approach and Experimental Validation.
    Wang YC; Hui JR; Xiao G; Ma QL
    Chin J Integr Med; 2023 Mar; 29(3):244-252. PubMed ID: 36044117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of peach kernel and safflower herb-pair for the treatment of liver fibrosis based on network pharmacology and molecular docking technology: A review.
    Huang L; Yu Q; Peng H; Zhen Z
    Medicine (Baltimore); 2023 Apr; 102(16):e33593. PubMed ID: 37083803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of Baihedihuang decoction as a treatment for breast cancer related anxiety: A network pharmacology and molecular docking study.
    Li ZH; Yang GH; Wang F
    World J Clin Cases; 2022 Nov; 10(33):12104-12115. PubMed ID: 36483797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of Erianin anti-triple negative breast cancer based on transcriptomics methods and network pharmacology.
    Li M; Zhao Y; Li H; Kang S; Deng X; Sheng M
    Aging (Albany NY); 2024 Feb; 16(3):2848-2865. PubMed ID: 38329441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study the Mechanism of Gualou Niubang Decoction in Treating Plasma Cell Mastitis Based on Network Pharmacology and Molecular Docking.
    Wu Z; Yang Q; Ma H
    Biomed Res Int; 2022; 2022():5780936. PubMed ID: 35757473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential mechanism of Bletilla striata in the treatment of ulcerative colitis determined through network pharmacology, molecular docking, and in vivo experimental verification.
    Gong S; Lv R; Fan Y; Shi Y; Zhang M
    Naunyn Schmiedebergs Arch Pharmacol; 2023 May; 396(5):983-1000. PubMed ID: 36576506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
    Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
    J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.